Budget crunch, political battles shape 2012 policy agenda.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 41
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 1
Results: 10
1
2
Pharmacists can help heart failure patients with recommended doses of appropriate drugs.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 40
- By:
- Publication type:
- Article
3
Rivaroxaban lowers risks in patients with ACS.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 40
- By:
- Publication type:
- Article
4
Almost half of new molecular entities approved in 2011 considered significant therapeutic advances.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 26
- By:
- Publication type:
- Article
5
Linaclotide: A guanylate cyclase type-C agonist for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 15
- By:
- Publication type:
- Article
6
Plans re-evaluate their COPD programs in light of changes.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 8
- By:
- Publication type:
- Article
7
Specialty tier falls out of favor because of access issues.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 5
- By:
- Publication type:
- Article
8
Quality programs best served with clinical data analytics.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 5
- By:
- Publication type:
- Article
9
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 4
- Publication type:
- Article
10
New indications.
- Published in:
- Formulary, 2012, v. 47, n. 1, p. 3
- By:
- Publication type:
- Article